IP Library Granted Patent US 7,674,451
Granted Patent B2
US 7,674,451 · App. 12/071,002 · Granted Mar 9, 2010

Cosmetic or pharmaceutical composition comprising peptides, uses and treatment processes

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,674,451
App. No.
12/071,002
Granted
Mar 9, 2010
Kind
B2
Abstract

The present invention relates to the use of at least one peptide, with the sequence (AA)n -Arg-Gly-Ser-(AA)n, where (AA) is any amino acid or one of its derivatives, and N is an integer between 0 and 3, as an active ingredient, in or for the preparation of a cosmetic and/or dermatological and/or pharmaceutical composition. The invention also relates to its use in order to treat, inter alia, the cutaneous manifestations of aging and/or its use in order to act against cellulite. The invention is, in the same way, related to a composition containing it as well as a process of cosmetic treatment of the skin using the said peptide or the said composition.

Claims (18)

1. A method for treating or inhibiting a loss of elasticity, said method comprising administering to a subject in need thereof an effective amount of a cosmetic, dermatological, or pharmaceutical composition comprising an acceptable medium and a peptide of formula (I):

(AA)n-Arg-Gly-Ser-(AA)n  (I),

wherein (AA) is an unspecified amino acid or derivative thereof, and n is an integer ranging between 0 and 3.

2. The method according to claim 1 , wherein the peptide of formula (I) has the sequence Arg-Gly-Ser.

3. The method according to claim 1 , wherein the peptide of formula (I) has a protective group, wherein the protective group is either an acylation of the amino-terminal, acetylation of the amino terminal, an amidation of the carboxy terminal, or esterification of the carboxy-terminal.

4. The method according to claim 1 , wherein the peptide of formula (I) is present in the composition at a concentration ranging approximately between 0.005 and 500 ppm.

5. The method according to claim 1 , wherein said composition is in a form for topical cutaneous application.

6. The method according to claim 1 , wherein the peptide of formula (I) is solubilized in one or more solvents selected from the group consisting of water, ethanol, propanol, isopropanol, propylene glycol, butylene glycol, dipropylene glycol, ethoxylated diglycol, propoxylated diglycol, cyclic polyol, petroleum jelly, liposome, and a vegetable oil.

7. The method according to claim 1 , wherein the peptide of formula (I) is solubilized in a liposome.

8. The method according claim 1 , wherein the composition is in a form selected from the group consisting of an aqueous solution, hydroalcoholic solution, oily solution, oil-in-water emulsion, water-in-oil emulsion, multiple emulsions, cream, suspension, powders a milk, a serum, a pomade, a gel, a paste, a foam, and a stick.

9. The method according to claim 1 , wherein the composition is administered topically.

10. The method according to claim 1 , wherein said loss of elasticity comprises one or more manifestations selected from the group consisting of wrinkles, fine lines, limp skin, slackened skin, slimmer looking skin, loss of skin tone, dull skin, skin which lacks radiance, and orange-peel skin.

11. The method according to claim 1 , wherein the peptide of formula (I) is adsorbed on powdered organic polymers or a mineral support.

12. The method according to claim 11 , wherein the mineral support is selected from the group consisting of bentonite and talc.

13. A method for treating a loss of elasticity, said method comprising administering to a subject an effective amount of a cosmetic, dermatological, or pharmaceutical composition comprising an acceptable medium and a peptide of formula (I):

(AA)n-Arg-Gly-Ser-(AA)n  (I),

wherein (AA) is an unspecified amino acid, and n is an integer ranging between 0 and 3, and

wherein said loss of elasticity comprises one or more manifestations selected from the group consisting of wrinkles, fine lines, limp skin, slackened skin, slimmer looking skin, loss of skin tone, dull skin, skin which lacks radiance, and orange-peel skin.